Business

Full Year Trading Update

One Health Group plc reported a strong financial year ended March 31, 2026, with revenue reaching £32.0 million, a 13% increase from the previous year, and underlying EBITDA expected to be ahead of market expectations. The company saw significant growth across key performance indicators, including an 11% rise in new NHS patient referrals to 18,931 and a 15% increase in surgical procedures to 8,113. Construction of their first Surgical Hub in Scunthorpe is on track with an estimated cost of £8m to £9m. The company ended the fiscal year with £11.1 million in cash, positioning it well for continued organic growth and the execution of its surgical hub development strategy. Disclaimer*

One Health Group PlcApril 27, 20264
Full Year Trading Update

About this update from One Health Group Plc

  One Health Group plc ("One Health", the "Company" or the "Group")   Full Year Trading Update   FY 26 revenue and underlying EBITDA ahead of market expectations Strong growth across all KPIs   One Health Group plc (AIM: OHGR), the independent provider of NHS-funded surgical procedures for patients referred from the NHS through 'Patient Choice', provides the following trading update for the year ended 31 March 2026 ("FY 26") , show ing continued growth, ahead of market expectations . 1   Key Highlights       FY 26   FY 25   Growth   Revenue £32.0m £28.4m 13% New NHS patient referrals  18,931  17,020 11% Number of consultations  50,774  42,238 20% Number of surgical procedures  8,113  7,043 15% Number of consultants (excluding anaesthetists) 88 80 10% Number of Outreach Clinics 40 37 8% Number of Surgical Operating Facilities 14 10 40%   Surgical Hub progress ·    As announced on 23 February , construction of the Company's first Surgical Hub in Scunthorpe, Lincolnshire, has commenced ·    The project is on track to be delivered within the one-year construction period and in line with the previous cost estimate of £8m to £9 m ·    Further locations in underserved areas with high NHS demand continue to be explored for preliminary assessment of suitability for future surgical hubs   Outlook The Board is confident in the Company's strategy to drive continued organic growth through increased patient referrals, a strong pipeline of new surgeons, and additional surgical capacity in existing and new independent sector hospitals. The Company continues to support the delivery of the challenging NHS waiting list reduction targets set by the Government.   The Company is expected to deliver growth at the revenue and underlying EBITDA levels for FY 26, ahead of market expectations 1 . Cash at 31 March 2026 was £11.1m (FY 25: £11.4m) with the Company remaining well-funded to deliver further organic growth and execute the carefully planned delivery of the Group's first surgical hub to accelerate growth and improve profitability.   1 Management understands consensus market estimates for revenue and underlying EBITDA for FY 26 to be £29.4 million and £2.3 million respectively.   Adam Binns, Chief Executive Officer, commented: "We are delighted to deliver a strong year end trading update ahead of market expectations for our first full year following our AIM listing and that construction of our first surgical hub commenced during this period. NHS national waiting lists remain very high, despite continued NHS efforts and recent modest reductions, and we are proud that One Health remains well-positioned to continue to reduce pressure on the NHS by providing free high-quality care across underserved areas."   If you wish to keep up to date on Company news please email: [email protected]   This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.   For more information, please contact:   One Health Group plc Derek Bickerstaff, Chairman Adam Binns, CEO   www.onehealth.co.uk/investors Via Walbrook PR Panmure Liberum (Nominated Adviser and Broker) Emma Earl, Will Goode, Mark Rogers Rupert Dearden   Tel: +44 (0)20 3100 2000 Walbrook PR (Media & Investor Relations) Alice Woodings / Paul McManus / Rachel Broad Tel: +44 (0)20 7933 8780 or [email protected] Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893 /                                                                     +44 (0)7747 515 393     About One Health Group plc ( www.onehealth.co.uk ) One Health engages 88 NHS Consultants (excluding anaesthetists) who sub-specialise in the various surgeries offered by the Company, through a growing network of community-based outreach clinics and surgical operating locations. One Health continues to deliver strong growth and in the year to March 2026 provided much needed care to 18,931 new patients, through over 50,000 consultations and over 8,000 surgical procedures. One Health deploys surgeons and anaesthetists that are mostly employed by the NHS, on a subcontracted basis. It currently works with over 140 professionals across 14 independent hospitals and 40 outreach clinics. Within these community-based outreach clinics all consultations and post operative physiotherapy is delivered where required, reducing patient inconvenience and excess travel.   One Health's activities are focused on areas where NHS patient needs are under-supplied by the local NHS service, population density is relatively high and the level of private medical insurance or the ability to self-fund is relatively low. Currently, the Company's activities are focused in Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue is derived from 29 ICBs across England as well as contracts with local NHS trusts to transfer their internal waiting list patients to One Health for quicker treatment. One Health's business model has focused to date on four main areas: orthopaedics, spine, general surgery and gynaecology, with urology introduced at the end of FY25.   Spine and orthopaedics are particularly attractive areas for One Health as the Directors believe that they benefit from powerful growth drivers in terms of an ageing demographic, physical inactivity and an increasing proportion of the population being categorised as obese. Within orthopaedics, the most common surgeries performed by One Health are knee and hip replacements.   Online investor presentation Click below for the latest online presentation by Derek Bickerstaff, Chairman and Adam Binns, Chief Executive Officer, which offers insights into the Company's growth strategy and long-term vision: https://sparklive.lseg.com/ONEHEALTHGROUP/events/3c988809-19ad-454c-af31-cfe86bfe7da5/one-health-group-half-year-results-announcement    

View stock analysis, news, and events for One Health Group Plc

More from One Health Group Plc

All One Health Group Plc news →